Literature DB >> 30665899

Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer.

Ali Ayhan1, Hanifi Şahin2,3, Mustafa Erkan Sari4,3, Ibrahim Yalçin2,3, Ali Haberal1, Mehmet Mutlu Meydanli2,3.   

Abstract

OBJECTIVE: The purpose of this study was to assess the prognostic significance of lymphovascular space invasion in women with low-risk endometrial cancer.
METHODS: A dual-institutional, retrospective department database review was performed to identify patients with 'low-risk endometrial cancer' (patients having <50% myometrial invasion with grade 1 or 2 endometrioid endometrial cancer according to their final pathology reports) at two gynecologic oncology centers in Ankara, Turkey. Demographic, clinicopathological and survival data were collected.
RESULTS: We identified 912 women with low-risk endometrial cancer; 53 patients (5.8%) had lymphovascular space invasion. When compared with lymphovascular space invasion-negative patients, lymphovascular space invasion-positive patients were more likely to have post-operative grade 2 disease (p<0.001), deeper myometrial invasion (p=0.003), and larger tumor size (p=0.005). Patients with lymphovascular space invasion were more likely to receive adjuvant therapy when compared with lymphovascular space invasion-negative women (11/53 vs 12/859, respectively; p<0.001). The 5-year recurrence-free survival rate for lymphovascular space invasion-positive women was 85.5% compared with 97.0% for lymphovascular space invasion-negative women (p<0.001). The 5-year overall survival rate for lymphovascular space invasion-positive women was significantly lower than that of lymphovascular space invasion-negative women (88.2% vs 98.5%, respectively; p<0.001). Age ≥60 years (HR 3.13, 95% CI 1.13 to 8.63; p=0.02) and positive lymphovascular space invasion status (HR 6.68, 95% CI 1.60 to 27.88; p=0.009) were identified as independent prognostic factors for decreased overall survival.
CONCLUSIONS: Age ≥60 years and positive lymphovascular space invasion status appear to be important prognostic parameters in patients with low-risk endometrial cancer who have undergone complete surgical staging procedures including pelvic and para-aortic lymphadenectomy. Lymphovascular space invasion seems to be associated with an adverse prognosis in women with low-risk endometrial cancer; this merits further assessment on a larger scale with standardization of the lymphovascular space invasion in terms of presence/absence and quantity. © IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  endometrial neoplasms; lymphovascular space invasion; survival analysis

Year:  2019        PMID: 30665899     DOI: 10.1136/ijgc-2018-000069

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  6 in total

1.  Association of Tumor Size With Myometrial Invasion, Lymphovascular Space Invasion, Lymph Node Metastasis, and Recurrence in Endometrial Cancer: A Meta-Analysis of 40 Studies With 53,276 Patients.

Authors:  Xiaoying Jin; Chunjuan Shen; Xiaodi Yang; Yayuan Yu; Jianzhang Wang; Xuan Che
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

2.  Effect of Pelvic Lymphadenectomy on Survival in Patients with Low-Risk Early-Stage Endometrial Cancer Diagnosed Intraoperatively Using Frozen Tissue Sections: A Retrospective Analysis.

Authors:  Caiyan Liu; Jianguo Zhao; Shasha Liu; Yaomei Ma; Yun Yang; Pengpeng Qu
Journal:  Cancer Manag Res       Date:  2020-10-29       Impact factor: 3.989

3.  Surgicopathological Outcomes and Survival in Carcinoma Body Uterus: A Retrospective Analysis of Cases Managed by Laparoscopic Staging Surgery in Indian Women.

Authors:  Dipak Jagdishchandra Limbachiya
Journal:  Gynecol Minim Invasive Ther       Date:  2020-08-01

Review 4.  The Prediction of Recurrence in Low-Risk Endometrial Cancer: Is It Time for a Paradigm Shift in Adjuvant Therapy?

Authors:  Mohamed Laban; Seif Tarek El-Swaify; Sara H Ali; Mazen A Refaat; Mohamed Sabbour; Nourhan Farrag; Alaa Sayed Hassanin
Journal:  Reprod Sci       Date:  2021-04-15       Impact factor: 3.060

5.  Chemotherapy versus chemoradiotherapy for FIGO stages IB1 and IIA1 cervical squamous cancer patients with lymphovascular space invasion: a retrospective study.

Authors:  Hao Zhang; Rao Yu; Lan Zhang; Rong Wang; Lin Xiao
Journal:  BMC Cancer       Date:  2022-02-23       Impact factor: 4.430

6.  Pre-treatment risk assessment of women with endometrial cancer: differences in outcomes of molecular and clinical classifications in the Slovenian patient cohort.

Authors:  Jure Knez; Monika Sobocan; Urska Belak; Rajko Kavalar; Mateja Zupin; Tomaz Büdefeld; Uros Potocnik; Iztok Takac
Journal:  Radiol Oncol       Date:  2021-09-17       Impact factor: 2.991

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.